Atlas Trials

A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.

Clinical trial NCT06339216 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06339216
Sponsor
Chinese PLA General Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2024-03-20
Primary completion
2024-12-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.